S302: COST-EFFECTIVENESS OF KTE-X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA

Authors: M. Marchetti, C. Visco

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000844100.62990.c2

Source: Full article


Abstract

No abstract found.